Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ARDELYX, INC. | Executive Vice President, Corporate Development and Strategy | Common Stock | 160K | $1.24M | $7.73 | Mar 25, 2024 | Direct |
ARDELYX, INC. | Executive Vice President, Corporate Development and Strategy | Stock Option (Right to Buy) | 205K | $476K | $2.32 | Mar 25, 2024 | Direct |
CAPRICOR THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 30K | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARDX | ARDELYX, INC. | Mar 25, 2024 | 2 | $0 | 4 | Mar 27, 2024 | Executive Vice President, Corporate Development and Strategy |
ARDX | ARDELYX, INC. | Mar 25, 2024 | 0 | $0 | 3 | Mar 27, 2024 | Executive Vice President, Corporate Development and Strategy |
CAPR | CAPRICOR THERAPEUTICS, INC. | Jan 2, 2024 | 4 | $0 | 4 | Jan 4, 2024 | Director |
CAPR | CAPRICOR THERAPEUTICS, INC. | Sep 1, 2023 | 1 | $0 | 4 | Sep 6, 2023 | Director |
CAPR | CAPRICOR THERAPEUTICS, INC. | Sep 1, 2023 | 0 | $0 | 3 | Sep 6, 2023 | Director |